The Truth About GLP 1s: Assessing the Risk of Medullary Thyroid Cancer in Humans SRx Exploring LDN for Autoimmune Support Low Dose Naltrexone (LDN) is gaining attention for its potential to support patients with autoimmune conditions, such as Multiple Sclerosis, Rheumatoid Arthritis, Hashimoto's, Crohn's disease, and Dosing Schedule DocDay GLP 1 receptor agonists should not be combined with DPP 4 inhibitors, as there is no added glucose lowering benefit beyond that of the GLP 1 RA alone. Both drug classes work through overlapping mechanisms involving